Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Blood cancer journal - 10(2020), 11 vom: 20. Nov., Seite 121 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pophali, Prateek [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 06.05.2021 Date Revised 06.05.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41408-020-00387-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317862413 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317862413 | ||
| 003 | DE-627 | ||
| 005 | 20231225164143.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41408-020-00387-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317862413 | ||
| 035 | |a (NLM)33219206 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pophali, Prateek |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.05.2021 | ||
| 500 | |a Date Revised 06.05.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 700 | 1 | |a Matin, Aasiya |e verfasserin |4 aut | |
| 700 | 1 | |a Mangaonkar, Abhishek A |e verfasserin |4 aut | |
| 700 | 1 | |a Carr, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a Binder, Moritz |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Kali, Aref |e verfasserin |4 aut | |
| 700 | 1 | |a Begna, Kebede H |e verfasserin |4 aut | |
| 700 | 1 | |a Reichard, Kaaren K |e verfasserin |4 aut | |
| 700 | 1 | |a Alkhateeb, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Mithun V |e verfasserin |4 aut | |
| 700 | 1 | |a Tefferi, Ayalew |e verfasserin |4 aut | |
| 700 | 1 | |a Hogan, William J |e verfasserin |4 aut | |
| 700 | 1 | |a Litzow, Mark R |e verfasserin |4 aut | |
| 700 | 1 | |a Patnaik, Mrinal M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood cancer journal |d 2011 |g 10(2020), 11 vom: 20. Nov., Seite 121 |w (DE-627)NLM219701628 |x 2044-5385 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2020 |g number:11 |g day:20 |g month:11 |g pages:121 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41408-020-00387-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2020 |e 11 |b 20 |c 11 |h 121 | ||